BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19248666)

  • 1. Crossing borders: surgically mediated drug delivery techniques.
    Asthagiri AR; Baggenstos M; Lonser RR
    Clin Neurosurg; 2008; 55():27-34. PubMed ID: 19248666
    [No Abstract]   [Full Text] [Related]  

  • 2. Convection-enhanced and local delivery of targeted cytotoxins in the treatment of malignant gliomas.
    Muro K; Das S; Raizer JJ
    Technol Cancer Res Treat; 2006 Jun; 5(3):201-13. PubMed ID: 16700617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Local therapy of primary brain tumors].
    Westphal M; Stummer W
    Nervenarzt; 2010 Aug; 81(8):913-4, 916-7. PubMed ID: 20664996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma.
    Parney IF; Kunwar S; McDermott M; Berger M; Prados M; Cha S; Croteau D; Puri RK; Chang SM
    J Neurosurg; 2005 Feb; 102(2):267-75. PubMed ID: 15739554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignant gliomas--radiotherapy].
    Schratter-Sehn A
    Wien Med Wochenschr; 2006 Jun; 156(11-12):342-5. PubMed ID: 16944365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial chemotherapy with sustained-release polymer systems for the treatment of malignant gliomas.
    Olivi A; Brem H
    Recent Results Cancer Res; 1994; 135():149-54. PubMed ID: 8047689
    [No Abstract]   [Full Text] [Related]  

  • 7. Editors' remarks: Evolving concepts for local therapies for glioma.
    Westphal M; Tonn JC
    Acta Neurochir Suppl; 2003; 88():VII-IX. PubMed ID: 14531552
    [No Abstract]   [Full Text] [Related]  

  • 8. Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors.
    Ferguson S; Lesniak MS
    Curr Drug Deliv; 2007 Apr; 4(2):169-80. PubMed ID: 17456036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results.
    Vogelbaum MA; Sampson JH; Kunwar S; Chang SM; Shaffrey M; Asher AL; Lang FF; Croteau D; Parker K; Grahn AY; Sherman JW; Husain SR; Puri RK
    Neurosurgery; 2007 Nov; 61(5):1031-7; discussion 1037-8. PubMed ID: 18091279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locoregional approaches to therapy with gliomas as the paradigm.
    Liang BC; Weil M
    Curr Opin Oncol; 1998 May; 10(3):201-6. PubMed ID: 9619355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin.
    Sampson JH; Raghavan R; Provenzale JM; Croteau D; Reardon DA; Coleman RE; Rodríguez Ponce I; Pastan I; Puri RK; Pedain C
    AJR Am J Roentgenol; 2007 Mar; 188(3):703-9. PubMed ID: 17312057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in chemotherapy for brain tumors.
    Conrad CA; Milosavljevic VP; Yung WK
    Neurol Clin; 1995 Nov; 13(4):795-812. PubMed ID: 8583997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracavitary chemotherapy for glioblastoma: present status and future directions.
    Westphal M; Lamszus K; Hilt D
    Acta Neurochir Suppl; 2003; 88():61-7. PubMed ID: 14531563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of malignant gliomas.
    Krauseneck P; Müller B
    Recent Results Cancer Res; 1994; 135():135-47. PubMed ID: 7519355
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiotherapy and chemotherapy for gliomas.
    Delattre JY; Uchuya M
    Curr Opin Oncol; 1996 May; 8(3):196-203. PubMed ID: 8804817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapeutic wafers in treatment of malignant cerebral glioma. Assessment of a Cochrane review].
    Kosteljanetz M; Poulsen HS
    Ugeskr Laeger; 2010 Jan; 172(3):214-7. PubMed ID: 20089214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New delivery systems for brain tumor therapy.
    Sipos EP; Brem H
    Neurol Clin; 1995 Nov; 13(4):813-25. PubMed ID: 8583998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain necroses after intraarterial chemotherapy and irradiation of malignant gliomas--a complication of both ACNU and BCNU?
    Tonn JC; Roosen K; Schachenmayr W
    J Neurooncol; 1991 Dec; 11(3):241-2. PubMed ID: 1823343
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial.
    Olivi A; Grossman SA; Tatter S; Barker F; Judy K; Olsen J; Bruce J; Hilt D; Fisher J; Piantadosi S;
    J Clin Oncol; 2003 May; 21(9):1845-9. PubMed ID: 12721262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comprehensive therapy of malignant glioma of the brain].
    Marchenko SV
    Vopr Onkol; 1997; 43(6):610-2. PubMed ID: 9479362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.